Santa Cruz Biotechnology supplies a comprehensive collection of Myofibroblasts monoclonal antibodies for various research applications. Myofibroblasts monoclonal antibodies are suitable for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Myofibroblasts play a crucial role in wound healing and tissue repair, characterized by their ability to contract and produce extracellular matrix components. Myofibroblasts are implicated in fibrotic diseases, making their study essential for understanding pathological conditions such as liver cirrhosis and pulmonary fibrosis. The regulation of Myofibroblast activity is vital for maintaining tissue homeostasis and preventing excessive scarring. Researchers can explore the molecular pathways involved in Myofibroblast differentiation and activation using specific markers and signaling molecules. Understanding the behavior of Myofibroblasts in different physiological states helps advance therapeutic strategies for fibrotic disorders. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of Myofibroblast biology and develop targeted treatments for related pathologies.